Cubist Systematic Strategies’s Cardiovascular Systems, Inc. CSII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-90,012
Closed -$1.23M 4707
2022
Q4
$1.23M Sell
90,012
-81,987
-48% -$1.14M 0.01% 2263
2022
Q3
$2.38M Sell
171,999
-146,512
-46% -$2.18M 0.01% 1824
2022
Q2
$4.57M Buy
318,511
+271,649
+580% +$4.71M 0.03% 1066
2022
Q1
$1.06M Sell
46,862
-129,996
-74% -$2.52M 0.01% 1982
2021
Q4
$3.32M Buy
176,858
+162,417
+1,125% +$4.34M 0.03% 942
2021
Q3
$474K Buy
14,441
+7,992
+124% +$298K 0.01% 2071
2021
Q2
$275K Sell
6,449
-786
-11% -$30.7K ﹤0.01% 2391
2021
Q1
$277K Sell
7,235
-2,712
-27% -$115K ﹤0.01% 2303
2020
Q4
$435K Sell
9,947
-24,772
-71% -$932K 0.01% 1847
2020
Q3
$1.37M Buy
34,719
+8,565
+33% +$277K 0.02% 1152
2020
Q2
$825K Buy
26,154
+10,414
+66% +$389K 0.01% 1300
2020
Q1
$554K Sell
15,740
-213
-1% -$8.98K 0.02% 1190
2019
Q4
$775K Sell
15,953
-11,825
-43% -$538K 0.01% 1313
2019
Q3
$1.32M Buy
27,778
+13,529
+95% +$636K 0.03% 840
2019
Q2
$612K Sell
14,249
-824
-5% -$32K 0.01% 1349
2019
Q1
$583K Buy
15,073
+968
+7% +$32.8K 0.02% 1086
2018
Q4
$402K Buy
+14,105
New +$448K 0.02% 1093
2018
Q3
Sell
-3,062
Closed -$99K 2148
2018
Q2
$99K Sell
3,062
-1,246
-29% -$34.3K 0.01% 1539
2018
Q1
$94K Buy
4,308
+3,765
+693% +$90.5K 0.01% 1604
2017
Q4
$13K Sell
543
-4,118
-88% -$104K ﹤0.01% 1847
2017
Q3
$131K Buy
4,661
+256
+6% +$7.79K 0.01% 1576
2017
Q2
$142K Sell
4,405
-3,411
-44% -$104K 0.01% 1384
2017
Q1
$221K Buy
+7,816
New +$208K 0.02% 1116
2016
Q4
Sell
-9,543
Closed -$227K 1939
2016
Q3
$227K Buy
+9,543
New +$209K 0.01% 1183
2015
Q4
Sell
-13,800
Closed -$219K 2009
2015
Q3
$219K Buy
13,800
+12,800
+1,280% +$323K 0.01% 1419
2015
Q2
$26K Buy
+1,000
New +$32.3K ﹤0.01% 1747
2014
Q4
Sell
-2,700
Closed -$64K 2093
2014
Q3
$64K Buy
2,700
+1,334
+98% +$37.9K ﹤0.01% 1609
2014
Q2
$43K Buy
+1,366
New +$39.4K ﹤0.01% 1416

Other funds holding CSII

Cubist Systematic Strategies's CSII Position: Q1 2023 in Review

Cubist Systematic Strategies sold out of Cardiovascular Systems, Inc. (CSII) in Q1 2023, closing a stake of 90,012 shares — an estimated $1.23M sold.

Cubist Systematic Strategies first reported a position in CSII in Q2 2014 and held it in 28 quarters. The position peaked at $4.57M in Q2 2022. 150 funds tracked by Wall St. Rank hold CSII as of Q1 2023.

  • Cubist Systematic Strategies reported no remaining Cardiovascular Systems, Inc. position as of Q1 2023 after selling out during the quarter.
  • Cubist Systematic Strategies sold 90,012 Cardiovascular Systems, Inc. shares in Q1 2023, an estimated $1.23M.
  • Cubist Systematic Strategies first reported a position in Cardiovascular Systems, Inc. in Q2 2014 and held it in 28 quarters.
  • Cubist Systematic Strategies's Cardiovascular Systems, Inc. position peaked at $4.57M in Q2 2022.
  • 150 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q1 2023.

Based on Cubist Systematic Strategies's 13F filing for Q1 2023, filed 15 May 2023.